Italian Absorb Registry

Summary

The investigators aim at evaluating the long-term (5-year) clinical outcome following Absorb BVS implantation in a real world, all-comers population of consecutive patients, as treated according to the indications, techniques and protocols used in the participating institutions.

Conditions

• Coronary Artery Disease

Interventions

DEVICE

PCI with Absorb scaffold

Implantation of biovascular scaffold during PCI

Sponsors & Collaborators

• Fatebenefratelli and Ophthalmic Hospital

  collaborator OTHER

• Bolognini Hospital

  collaborator UNKNOWN

• Ospedale Regionale di Aosta

  collaborator UNKNOWN

• Ospedali Riuniti di Ancona

  collaborator UNKNOWN

• S. Giacomo Hospital

  collaborator OTHER

• Azienda U.L.S.S n.9 Ospedale di Treviso Ca Foncello

  collaborator UNKNOWN

• Ospedale San Bortolo di Vicenza

  collaborator OTHER

• Azienda Ospedaliera Brotzu

  collaborator OTHER

• San Giuseppe Moscati Hospital

  collaborator OTHER

• Azienda Sanitaria Locale USL 13 Ospedale Mazzoni di Ascoli Piceno

  collaborator UNKNOWN

• S. Andrea Hospital

  collaborator OTHER

• Ospedale Monaldi di Napoli

  collaborator UNKNOWN

• Azienda Ospedaliera di Padova

  collaborator OTHER

• Ospedale della Misericordia di Grosseto

  collaborator UNKNOWN

• Ospedale Santa Corona di Pietra Ligure

  collaborator UNKNOWN

• Istituto Di Ricerche Farmacologiche Mario Negri

  collaborator OTHER

• Ospedale Santa Croce-Carle Cuneo

  lead OTHER

Principal Investigators

• Alfonso Ielasi, MD · AO Seriate

• Bernardo Cortese, MD · AO Fatebenefratelli

• Donatella Corrado, PhD · Istituto Di Ricerche Farmacologiche Mario Negri

Eligibility

Max Age

75 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2013-05-31

Primary Completion

2016-11-30

Completion

2021-05-31

Countries

• Italy

Study Locations